Pomerantz Defeats Recro Pharma Motion to Dismiss

On March 1, 2021, Pomerantz received a very favorable decision from Judge Michael M. Baylson in Alberici v. Recro Pharma, Inc. et al, 2:18-cv-02279, a case currently pending in the Eastern District of Pennsylvania, when U.S. District Judge Michael M. Baylson issued a decision denying Defendants’ motion to dismiss the Second Amended Complaint. The Court issued a decision denying defendants’ motion to dismiss the Second Amended Complaint, holding that pled sufficient facts to support the reasonable inference…